Evidence map›Paper›PMID 37182146›Full record

ArticleFrontiers in oncology2023

Long-term follow-up of colorectal cancer screening attendees identifies differences in

Cecilie Bucher-Johannessen, Einar Elvbakken Birkeland, Elina Vinberg, Vahid Bemanian, Geir Hoff, Paula Berstad, Trine B Rounge

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Tumor tissue-associatedFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Cecilie Bucher-JohannessenDepartment of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
Einar Elvbakken BirkelandCentre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
Elina VinbergDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Vahid BemanianDepartment of Pathology, Akershus University Hospital, Oslo, Norway.
Geir HoffDepartment of Research, Telemark Hospital Skien, Skien, Norway.
Paula BerstadSection for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo University Hospital, Oslo, Norway.
Trine B RoungeDepartment of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
Cancer Registry of Norway · NOUniversity of Oslo · NOAkershus University Hospital · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The microbiome has been implicated in the initiation and progression of colorectal cancer (CRC) in cross-sectional studies. However, there is a lack of studies using prospectively collected samples. Methods: From the Norwegian Colorectal Cancer Prevention (NORCCAP) trial, we analyzed 144 archived fecal samples from participants who were diagnosed with CRC or high-risk adenoma (HRA) at screening and from participants who remained cancer-free during 17 years of follow-up. We performed 16S rRNA sequencing of all the samples and metagenome sequencing on a subset of 47 samples. Differences in taxonomy and gene content between outcome groups were assessed for alpha and beta diversity and differential abundance. Results: Diversity and composition analyses showed no significant differences between CRC, HRA, and healthy controls. Conclusion: Using a longitudinal study design, we identified three taxa as being potentially associated with CRC. These should be the focus of further studies of microbial changes occurring prior to CRC diagnosis.

Indexed as

16S rRNAarchived fecal samplescolorectal cancer screeninglong term follow-upmetagenomemicrobiomesequencing

Identifiers

PMID37182146
PMCPMC10172651
OpenAlexW4367183913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.